Device
Tricuspid Valve Repair + LVAD for Heart Failure
Recruiting1 award3 criteria
Seattle, Washington
This trial is testing whether fixing a leaky heart valve during the implantation of a heart pump can help patients who have mild to moderate valve issues. The goal is to see if this combined approach improves heart function and reduces complications after surgery.
Transcatheter Valve Replacement
Transcatheter Valve Intervention for Tricuspid Regurgitation
Recruiting1 award4 criteria
New York, New York
This trial aims to test a new device, the LuX-Valve Plus System, in patients with severe tricuspid regurgitation who are not suitable for surgery. The study will evaluate how
Annuloplasty Ring
Percutaneous Ring Annuloplasty for Tricuspid Regurgitation
Recruiting1 award10 criteria
Hackensack, New Jersey
This trial tests a device called the CI annuloplasty ring, which helps a faulty heart valve close properly. It targets patients with moderate or worse tricuspid regurgitation. The ring is inserted through a vein in the neck and can be adjusted later to ensure it fits well and reduces the valve opening size.
Popular Filters
Trials for TR Patients
Transcatheter Valve Replacement
VDyne Valve Replacement for Tricuspid Regurgitation
Recruiting1 award6 criteria
Rochester, Minnesota
This trial is testing the VDyne System, a device designed to help treat severe tricuspid regurgitation, a condition where the heart valve doesn't close properly. It targets patients who have symptoms from this condition. The device works by helping the valve close correctly, improving blood flow in the heart. The VDyne System is part of a recent wave of devices developed to treat tricuspid regurgitation, a condition that has historically been undertreated due to high surgical risks.
Tricuspid Valve Replacement System
Edwards EVOQUE System for Tricuspid Valve Disease
Recruiting1 award3 criteria
Los Angeles, California
This trial is testing a new device called the Edwards EVOQUE system, which replaces a faulty heart valve. It targets patients with severe tricuspid regurgitation, a condition where the heart valve does not close properly. The new valve helps blood flow correctly through the heart, improving its function and reducing symptoms. The EVOQUE system has shown promise in initial studies for treating severe tricuspid regurgitation.
Trials With No Placebo
Behavioural Intervention
Mobile Health Exercise Regimen for Heart Valve Disease
Recruiting1 award1 criteria
Nashville, Tennessee
This trial is testing a home-based cardiac rehab program delivered using an app & digital tools to help improve health outcomes in those undergoing transcatheter heart valve interventions.
Transcatheter Valve Replacement
VDyne Valve Replacement for Tricuspid Regurgitation
Recruiting1 award6 criteria
Rochester, Minnesota
This trial is testing the VDyne System, a device designed to help treat severe tricuspid regurgitation, a condition where the heart valve doesn't close properly. It targets patients who have symptoms from this condition. The device works by helping the valve close correctly, improving blood flow in the heart. The VDyne System is part of a recent wave of devices developed to treat tricuspid regurgitation, a condition that has historically been undertreated due to high surgical risks.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.